Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 06/13/2024, as per the latest filing. These shares, acquired on 10/10/2022 as part of a restricted stock vesting and considered compensation, have an aggregate market value of $2,034. The planned sale follows a significant transaction history over the past few months, with a total of 257,984 securities sold, yielding gross proceeds of $226,918.44. The notice of the upcoming sale was given on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.

Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 06/13/2024, as per the latest filing. These shares, acquired on 10/10/2022 as part of a restricted stock vesting and considered compensation, have an aggregate market value of $2,034. The planned sale follows a significant transaction history over the past few months, with a total of 257,984 securities sold, yielding gross proceeds of $226,918.44. The notice of the upcoming sale was given on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.